Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NAMSA
NAMSA and TERUMO Announce Strategic Outsourcing Partnership
October 15, 2024
From
NAMSA
Via
Business Wire
NAMSA Acquires German Based CRI to Expand Clinical Research and Geographic Reach Across Europe
July 18, 2023
From
NAMSA
Via
Business Wire
Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
June 21, 2023
From
NAMSA
Via
Business Wire
NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO
March 27, 2023
From
NAMSA
Via
Business Wire
NAMSA Transforms Integrated MedTech Commercialization Solution: the NAMSA APEX Program™
November 17, 2022
From
NAMSA
Via
Business Wire
NAMSA Acquires UK-Based Perfectus Biomed Group to Enhance Customized Microbiological Solutions
October 04, 2022
From
NAMSA
Via
Business Wire
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development
September 08, 2022
From
NAMSA
Via
Business Wire
Tickers
NSPR
NAMSA to Acquire European-Based Medanex Clinic to Expand Early-Stage Preclinical Research Capabilities
March 30, 2022
From
NAMSA
Via
Business Wire
NAMSA Announces Intent to Acquire Contract Research Organization, ÅKRN
March 21, 2022
From
NAMSA
Via
Business Wire
NAMSA Expands Minneapolis Preclinical Laboratory to Meet Industry Demand for MedTech Research and Development Solutions
November 11, 2021
From
NAMSA
Via
Business Wire
NAMSA Acquires Leading Clinical Research Organization Clinlogix to Enhance Therapeutic Expertise and Global Footprint
August 02, 2021
From
NAMSA
Via
Business Wire
NAMSA First to Receive FDA ASCA Accreditation for Medical Device Biocompatibility Testing
July 28, 2021
From
NAMSA
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.